🇺🇸 FDA
Pipeline program

Luvadaxistat

TAK-831-2001

Phase 2 small_molecule completed

Quick answer

Luvadaxistat for Schizophrenia is a Phase 2 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 2 ClinicalTrials.gov record(s).

Program details

Company
NEUROCRINE BIOSCIENCES INC
Indication
Schizophrenia
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials